The Global Health Body Raises Alert Over Severe Scarcity of Weight-Loss Jabs

Less than one in 10 individuals eligible to benefit from GLP-1 drugs such as Wegovy can access them, states the World Health Organization as it issues its first guidance on the therapies.

Given in excess of 1,000,000,000 individuals worldwide now classified as obese, it is calling for broader and more equitable access to these injectable treatments.

Per projections, in excess of 2,000,000,000 could be living with obesity by 2030 unless action is taken.

"The new guidelines affirms that excess weight is a long-term condition that can be managed with holistic and ongoing care," said WHO director-general Tedros Adhanom Ghebreyesus.

Significant expense, constrained manufacturing, and distribution challenges are significant obstacles to widespread access to the injections that can help people shift significant body mass, says the organization.

Weight-Loss Drug Shortage

Even in the current most favorable case, the production of GLP-1 therapies could only cover approximately 100 million people – under 10% of eligible patients, per the WHO.

The guideline encourages governments and firms to widen availability, through strategies such as patent sharing.

A patent on a key compound – the primary component of a leading brand – is scheduled to end in a number of countries in 2026.

How Obesity Injections Operate

These medications mimick a biological compound to delay gastric emptying, reduce hunger and enhance the sense of being full so people consume fewer calories.

Patients usually begin shedding pounds after several weeks of starting on the weekly injections.

Studies suggests users may regain a significant portion a year later of discontinuing the treatment, when their typical hunger come back.

To be above a healthy weight raises your likelihood for experiencing health problems, including type 2 diabetes, cardiovascular issues, stroke, and some malignancies.

Excess weight concerns people in all nations and was responsible for millions of fatalities worldwide in 2024, per the WHO.